Published in Cancer Weekly, September 11th, 2001
In a recent study, published in the Journal of Clinical Oncology, G.N. Hortobagyi and colleagues in the Univeristy of Texas M.D. Anderson Cancer Center, Houston, reported results from a Phase I clinical trial using gene therapy to treat 18 patients with advanced breast and ovarian cancers. The liposome-complexed E1A gene from adenovirus was administered once weekly into the peritoneal or thoracic cavities of the participants. Transgene expression and tumor cell responses were...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.